Postmastectomy radiation therapy in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer: a retrospective exploratory cohort analysis of the adjuvant lapatinib and/or trastuzumab treatment optimization (ALTTO) trial [BIG 2-06/NCCTG N063D (Alliance)].

De Santis MC, Campbell C, Samy F, De Rose F, Meduri B, Lambertini M, Sotiriou C, Carnevale MG, Ferro A, Saura C, Choudhury A, Giandini C, Verderio P, Chumsri S, Appierto V, Piccart M, Pruneri G, Colciago RR, de Azambuja E, Di Cosimo S

Open source

DOI
10.1016/j.eclinm.2026.104079
Published
2026 Aug
Container
EClinicalMedicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2026.104079,
  title = {Postmastectomy radiation therapy in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer: a retrospective exploratory cohort analysis of the adjuvant lapatinib and/or trastuzumab treatment optimization (ALTTO) trial [BIG 2-06/NCCTG N063D (Alliance)].},
  author = {De Santis MC and Campbell C and Samy F and De Rose F and Meduri B and Lambertini M and Sotiriou C and Carnevale MG and Ferro A and Saura C and Choudhury A and Giandini C and Verderio P and Chumsri S and Appierto V and Piccart M and Pruneri G and Colciago RR and de Azambuja E and Di Cosimo S},
  year = {2026},
  journal = {EClinicalMedicine},
  doi = {10.1016/j.eclinm.2026.104079},
  url = {https://doi.org/10.1016/j.eclinm.2026.104079}
}

RIS

TY  - JOUR
TI  - Postmastectomy radiation therapy in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer: a retrospective exploratory cohort analysis of the adjuvant lapatinib and/or trastuzumab treatment optimization (ALTTO) trial [BIG 2-06/NCCTG N063D (Alliance)].
AU  - De Santis MC
AU  - Campbell C
AU  - Samy F
AU  - De Rose F
AU  - Meduri B
AU  - Lambertini M
AU  - Sotiriou C
AU  - Carnevale MG
AU  - Ferro A
AU  - Saura C
AU  - Choudhury A
AU  - Giandini C
AU  - Verderio P
AU  - Chumsri S
AU  - Appierto V
AU  - Piccart M
AU  - Pruneri G
AU  - Colciago RR
AU  - de Azambuja E
AU  - Di Cosimo S
PY  - 2026
JO  - EClinicalMedicine
DO  - 10.1016/j.eclinm.2026.104079
UR  - https://doi.org/10.1016/j.eclinm.2026.104079
ER  - 

APA

MC, D. S., C, C., F, S., F, D. R., B, M., M, L., C, S., MG, C., A, F., C, S., A, C., C, G., P, V., S, C., V, A., M, P., G, P., RR, C., E, D. A., & S, D. C. (2026). Postmastectomy radiation therapy in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer: a retrospective exploratory cohort analysis of the adjuvant lapatinib and/or trastuzumab treatment optimization (ALTTO) trial [BIG 2-06/NCCTG N063D (Alliance)].. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2026.104079

Source records